---
title: High Risk Breast Cancer Screening Program
nct_id: NCT00509509
overall_status: UNKNOWN
sponsor: Organisation for Oncology and Translational Research
study_type: OBSERVATIONAL
primary_condition: Breast Cancer
countries: Hong Kong
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT00509509.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT00509509"
ct_last_update_post_date: 2012-05-24
last_seen_at: "2026-05-12T07:23:36.585Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# High Risk Breast Cancer Screening Program

**NCT ID:** [NCT00509509](https://clinicaltrials.gov/study/NCT00509509)

## Key Facts

- **Status:** UNKNOWN
- **Study Type:** OBSERVATIONAL
- **Lead Sponsor:** Organisation for Oncology and Translational Research
- **Conditions:** Breast Cancer
- **CT.gov Last Update:** 2012-05-24

## Brief Summary

Objectives:

* To screen population with high risk for breast cancer
* To promote the concept and importance of surveillance mammography
* To find out the incidence of breast cancer in population who are in high risk for breast cancer
* To collect blood samples for molecular analysis

## Eligibility

- **Minimum age:** 41 Years
- **Sex:** FEMALE

```
Inclusion Criteria:

* Female
* \> 40 years of age
* Women who have first-degree relative suffered from breast cancer
* Women who have first-degree relative suffered from ovarian cancer
* Family history of male breast cancer
* Family history of breast cancer (not necessarily first degree relatives) diagnosed before age of 40
* Family history of breast cancer (not necessarily first degree relatives) affecting 2 or more family members
* Personal history of ovarian cancer
* Personal history of premalignant conditions of breast and ovary

Exclusion Criteria:

* Women with mammogram within one year
```

## Locations (1)

- UNIMED Medical Institute, Wan Chai, Hong Kong — _RECRUITING_

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.unimed medical institute|wan chai||hong kong` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT00509509.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT00509509*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*